About
Inert gas treatments
Areas of Focus
Categories
Small Molecule PharmaceuticalSeattle/Pacific Northwest
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
450
By Phase
PHASE2/PHASE3: 2PHASE1: 1
By Status
UNKNOWN: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT03635827Lead Sponsor
Xenon Inhalation for Treatment of Posttraumatic Stress Disorder
PHASE2/PHASE3Unknown
190 participants
Started: Jun 30, 2021 · Completed: Jul 31, 2021
NCT04432155Lead Sponsor
Xenon Inhalation for Treatment of Panic Disorder
PHASE2/PHASE3Unknown
200 participants
Started: Jun 30, 2021 · Completed: Dec 31, 2021
NCT04097080Lead Sponsor
Comparative Controlled Study of Analgesic, Antiasthenic and Anti-Anxiety Effects of Xenon in Patients With Parkinson's Disease
PHASE1Unknown
60 participants
Started: Dec 15, 2019 · Completed: Dec 31, 2021
Locations (1)
Headquarters
Portland, OR, United States
Map
Loading map...